TORONTO, April 25 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a global company providing a range of enabling products and services to the global life sciences markets, announced that Stephen DeFalco, President and Chief Executive Officer, will present at the Scotia Capital Pharmaceutical & Biotechnology Conference on Wednesday, April 26th at 11:40 am (ET).

Interested parties may access the live webcast by visiting the "Latest News" section of the homepage at www.mdsinc.com . An audio archive of the presentation will be available under Webcasts & Presentations in our "For Investors" section until May 26, 2006.

MDS Inc. has more than 8,800 highly skilled people in 27 countries. We provide a diverse range of superior products and services to increase our customers' speed, precision and productivity in the drug development and disease diagnosis processes. We are a global, values-driven life sciences company, recognized for our reliability and collaborative relationships as we help create better outcomes in the treatment of disease. Find out more at www.mdsinc.com or by calling 1-800-MDS-7222, 24 hours a day.

SOURCE  MDS Inc.
    -0-              04/25/2006
    /CONTACT: Sharon Mathers, Vice-President, Investor Relations and External
Communications, (416) 675-6777 x 4721, 

 Sharon.Mathers@mdsinc.com/
    (MDS. MDZ)

CO: MDS Inc.
ST: Ontario
IN: HEA
SU: CCA

    -30-

DV
-- TO049 --
4750 04/25/2006 08:00 EDT http://www.prnewswire.com